Page values for "Hydroxyurea"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 859,936 |
| _pageName | Page | Hydroxyurea |
| _pageTitle | String | Hydroxyurea |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Hydroxyurea |
| Short_definition | String | Hydroxyurea (hy-DROK-see-yoo-REE-uh) A drug used alone or with other cancer drugs or radiation therapy under the brand name Hydrea to treat certain types of chronic myeloid leukemia and head -throat cancer and used under the brand name Droxia to treat certain patients with sickle cell disease. It is |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |